In conclusion, Ki-67, p53 as well as abnormal reticulin pattern, but not p27 expression, could be used to define malignancy in adrenocortical neoplasms and differentiate ACCs from ACAs. This evidence concerns the gene TP53 and adrenal cortex neoplasm.